Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ON SALE OF IPEER
Mandate

VINGE ADVISES ON SALE OF IPEER

October 03, 2014

Vinge has advised Applewise in conjunction with its sale of Ipeer, Sweden’s leading corporate supplier of cloud- and hosting-based services, to TeliaSonera.

Ipeer had a turnover of SEK 56.7 million in 2013. The company has 65 employees and conducts operations in Stockholm, Karlstad and India.

As a result of the acquisition, Ipeer will constitute a part of Cygate’s operations within Telia Sverige’s corporate operations and will be included within Cygate’s cloud and hosting services division.

Vinge’s team consisted of partner Johan Göthberg together with, among others, associates Charlotta Järnstedt, Maria Dahlin, Linn Gustavsson and project assistant Josefine Malm.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026